Marc Wilson, CFO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 38,112 shares at $53.88 ($2.1M) on 2024-07-25, disclosed to the SEC on 2024-07-26.
Scheduled sale ($2.1M) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.88 | 19,056 | $1.0M | 50.0% |
| 2 | $53.88 | 19,056 | $1.0M | 50.0% |
| Total | $53.88 avg | 38,112 | $2.1M | 100% |
| Filing → |
| CRNX | SELL | 2024-07-02 | $2.8M | — | Filing → |
| CRNX | SELL | 2024-03-20 | $596K | — | Filing → |
| CRNX | SELL | 2024-01-04 | $355K | — | Filing → |